Physicians' Academy for Cardiovascular Education

The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?

June 5, 2017 - ERA-EDTA, Madrid Spain - Luis M Ruilope, MD – Hospital 12 de Octubre, Madrid, Spain

During a satellite symposium at the ERA-EDTA in Madrid, Spain, organised by PACE-CME, Luis M Ruilope, MD looked at the evidence showing that currently available therapies leave room for improvement in the reduction of CV events in patients with diabetes and chronic kidney disease.

Video navigation menu

  • Diabetes confers an increased risk of CV morbidity and mortality, which is further aggravated by chronic kidney disease 0:09
  • Optimal management of diabetes with renal disease implies a broad strategy targeting various risk factors 1:50
  • Summary of how CKD complicates management of diabetic patients 6:25
  • Unmet needs in management of diabetic patients with CKD 9:04

Educational information

Disclosures

CME Accreditation

This lecture was part of a CME accredited symposium: Managing CKD, Diabetes & CVD: Is epigenetics a new way forward? held at ERA-EDTA in Madrid, Spain.

Funding

The symposium was supported by an unrestricted educational grant from Resverlogix Corp